Propofol induces endothelial nitric oxide synthase phosphorylation and activation in human umbilical vein endothelial cells by inhibiting protein kinase Cd expression

European Journal of Anaesthesiology

Volumn 27, Issue 3, 2010, Pages 258-264

  Wang, Li ^a   Jiang, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Anaesthetics; Endothelial nitric oxide synthase; Endothelium; Human umbilical vein endothelial cells; Intravenous; Nitic oxide synthase system; Propofol; Protein kinase C isoforms; Protein kinase Cd

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CERAMIDE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROPOFOL; PROTEIN KINASE C DELTA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LONG TERM CARE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

CELL LINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROPOFOL; PROTEIN KINASE C-DELTA; UMBILICAL VEINS;

EID: 77953733329     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e3283311193     Document Type: Article

References (34)

1. Shafer A, Doze VA, Shafer SL, Whiter PF. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69:348-356.
2. Hutchens MP, Memtsoudis S, Sadovnikoff N. Propofol for sedation in neurointensive care. Neurocrit Care 2006; 4:54-62.
3. Mckeage K, Perry CM. Propofol: a review of its use in intensive care sedation of adults. CNS Drugs 2003; 17:235-272.
4. Chen RM, Chen TG, Chen TL, et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages. Ann N Y Acad Sci 2005; 1042:262-271.
5. Wu GJ, Chen TL, Chang CC, Chen RM. Propofol suppresses tumor necrosis factor-alpha biosynthesis in lipopolysaccharide-stimulated macrophages possible through downregulation of nuclear factor-kappa B-mediated toll-like receptor 4 gene expression. Chem Biol Interact 2009; 180:465-471.
6. Wang B, Luo T, Chen D, Ansley DM. Propofol reduces apoptosis and upregulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth Analg 2007; 105:1027-1033.
7. Cheng TH, Chen JJ, Chen CH, Wong KL. Effects of propofol on cyclic strain-induced endothelin-1 expression in human umbilical vein endothelial cells. Anesthesiology 2009; 110:74-80.
8. Yetik-Anacak G, Catravas JD. Nitric oxide and endothelium: history and impact on cardiovascular disease. Vasc Pharmacol 2006; 45:268-279.
9. Biscigil B, Chua YL, Pearson PJ, et al. Comparisons of the release of vasodilator substances from left and right cardiac chambers of the isolated perfused rabbit heart: implications for intraventricular thrombus formation. Nitric Oxide 2009; 20:259-263.
10. Kim JA, Montagnani M, Koh KK, Ouon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113:1888-1904.
11. Balligand JL, Feron O, Dessy C. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev 2009; 89:481-584.
12. Presley T, Vedam K, Velavutham M, et al. Activation of Hsp90-eNOS and increased NO generation attenuate respiration of hypoxia-treated endothelial cells. Am J Physiol Cell Physiol 2008; 295:C1281-C1291.
13. Partovian C, Zhuang Z, Moodie K, et al. PKCa activates eNOS and increases arterial blood flow in vivo. Circ Res 2005; 97:482-487.
14. Motley ED, Eguchi K, Patterson MM, et al. Mechanism of endothelial nitric oxide synthase phosphorylation and activation by thrombin. Hypertension 2007; 49:577-583.
15. Sugawara T, Ayer R, Jadhav V, et al. Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase. J Neurosci Res 2008; 86:3635-3643.
16. Kou R, SenBanerjee S, Jain MK, Michel T. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling. Biochemistry 2005; 44:15064-15073.
17. Wheatley C. The return of the Scarlet Pimpernel: cobalamin in inflammation II - cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS. J Nutr Environ Med 2007; 16:181-211.
18. Mehta VB, Zhou Y, Radulescu A, Besner GE. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Growth Factors 2008; 26:301-315.
19. Urano T, Ito Y, Akao M, et al. Andiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model. Arterioscler Thromb Vasc Biol 2008; 28:827-834.
20. Wagner L, Laczy B, Tamaskó M, et al. Cigarette smoke-induced alterations in endothelial nitric oxide synthase phosphorylation: role of protein kinase C. Endothelium 2007; 14:245-255.
21. Sun W, Lee TS, Zhu M, et al. Statins acitivate AMP-activated protein kinase in vitro and in vivo. Circulation 2006; 114:2655-2662.
22. Mount PF, Lane N, Venkatesan S, et al. Bradykinin stimulates endothelial cells fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis 2008; 200:28-36.
23. Hemmings HC Jr, Adamo AI, Hoffman MM. Biochemical characterization of the stimulatory effects of halothane and propofol on purified brain protein kinase C. Anesth Analg 1995; 81:1216-1222.
24. Wickley PJ, Ding X, Murray PA, Damron DS. Propofol-induced activation of protein kinase C isoforms in adult rat ventricular myocytes. Anesthesiology 2006; 104:970-977.
25. Wickley PJ, Ding X, Murray PA, Damron DS. Propofol decreases myofilament Ca2+ sensitivity via a protein kinase C-nitric oxide synthasedependent pathway in diabetic cardiomyocytes. Anesthesiology 2006; 104:978-987.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal Biochem 1976; 72:248-254.
27. Michell BJ, Chen Z, Tiganis T, et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMPdependent protein kinase. J Biol Chem 2001; 276:17625-17628.
28. MacKenzie S, Fleming I, Houslay MD, et al. Growth hormone and phorbol esters require specific protein kinase C isoforms to activate mitogenactivated protein kinases in 3T3-F442A cells. Biochem J 1997; 324:159-165.
29. Wei O, Xia Y. Proteasome inhibition down-regulates endothelial nitric-oxide synthase phosphorylation and function. J Biol Chem 2006; 281:21652-21659.
30. Thors B, Halldorsson H, Thorgeirsson G. Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt. FEBS Lett 2004; 573:175-180.
31. Sud N, Kumar S, Wedgwood S, Black SM. Modulation of PKCd signaling alters the shear stress-mediated increases in endothelial nitric oxide synthase transcription: role of STAT3. Am J Physiol Lung Cell Mol Physiol 2009; 296:L519-L526.
32. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334:661-665.
33. Mumby MC, Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev 1993; 73:673-699.
34. WuY, Song P, Xu J, et al. Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem 2007; 282:9777-9788.